Literature DB >> 11466580

Association between polymorphisms in candidate genes and morbid obesity.

D Evans1, A M Wolf, U Nellessen, S Ahle, B Kortner, H W Kuhlmann, U Beisiegel.   

Abstract

Polymorphisms in a number of candidate genes have been reported to be associated with obesity. We have determined the incidence of the following polymorphisms in the following candidate genes in a group of 388 morbid obese patients (mean body mass index (BMI) 52+/-8.01) who underwent gastric banding surgery: lipoprotein lipase (LpL) t-93 g and N291S; peroxisome proliferator receptor gamma (PPARgamma), P12A, P115Q and c1431t; peroxisome proliferator receptor alpha (PPARalpha) L162V; beta-adrenergic receptor 2 (beta-AR 2), Q27E; beta-adrenergic receptor 3 (beta-AR 3) W64R; uncoupling protein 1 (ucp-1), a-3826g, ucp-2, 45 bp insertion. Only for the ucp2 polymorphism did we find a statistically significant association with obesity. The beta-AR 3 W64R and ucp-1 a-3826g polymorphisms influenced the rate of the development of obesity and may act synergistically.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11466580     DOI: 10.1038/sj.ijo.0801690

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  3 in total

Review 1.  Uncoupling proteins: role in insulin resistance and insulin insufficiency.

Authors:  Catherine B Chan; Mary-Ellen Harper
Journal:  Curr Diabetes Rev       Date:  2006-08

2.  Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes.

Authors:  Mary Helen Black; Jun Wu; Miwa Takayanagi; Nan Wang; Kent D Taylor; Talin Haritunians; Enrique Trigo; Jean M Lawrence; Richard M Watanabe; Thomas A Buchanan; Anny H Xiang
Journal:  J Clin Endocrinol Metab       Date:  2015-01-13       Impact factor: 5.958

3.  Functional Characterization of the Obesity-Linked Variant of the β3-Adrenergic Receptor.

Authors:  Esraa Haji; Saeed Al Mahri; Yumna Aloraij; Shuja Shafi Malik; Sameer Mohammad
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.